Related Experiment Video
Updated: Jun 21, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Antiplatelet medications: old and emerging therapies
William M Stone1, Sailendra G Naidu, Alyssa Chapital
1Department of Surgery, Mayo Clinic, Phoenix, AZ 85054, USA. stone.william@mayo.edu
Abstract:
Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Angina IV: Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease V: Interprofessional Care
